We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£325.00
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Europe
Price data last checked 23 day(s) ago - will refresh soon
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£325 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 68 days · 68 data points (no recent data)
Price Distribution
Price distribution over 68 days • 1 price levels
Price Analysis
Most common price: £325 (68 days, 100.0%)
Price range: £325 - £325
Price levels: 1 different prices over 68 days
Product Specifications
- Format
- paperback
- ASIN
- B00E4G466A
- Domain
- Amazon UK
- Release Date
- 17 July 2013
- Listed Since
- 24 July 2013
Similar Products You Might Like
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan
The 2013 Report on Dipeptidyl Peptidase IV (DPP-IV) Inhibitors: World Market Segmentation by City
The 2023-2028 Outlook for Peptides and Heparin for Diabetes in Japan
The 2023-2028 Outlook for Peptides and Heparin for Diabetes in India
The 2023-2028 Outlook for Peptides and Heparin for Diabetes in the United States
The 2013-2018 Outlook for Drug Discovery Technologies in Africa, Europe & the Middle East
The 2023-2028 Outlook for Peptides and Heparin for Diabetes for US Zip Codes
The 2013-2018 Outlook for Drug Discovery Technologies in North America & the Caribbean
The 2013-2018 Outlook for Generic Drugs in India
The 2025-2030 World Outlook for Peptides and Heparin for Diabetes
Price unavailable
The 2013-2018 Outlook for Online Health and Pharmacy-Related Products in Europe
The 2016-2021 Outlook for Insulins and Anti-Diabetic Hormones and Synthetic Substitute Pharmaceuticals in India
The 2013-2018 Outlook for E-Paper Displays in Europe
The 2023-2028 Outlook for Animal Health Active Pharmaceutical Ingredients in the United States
The 2013-2018 Outlook for Small Molecule Kinase Inhibitors in Latin America
The 2016-2021 Outlook for Insulins and Anti-Diabetic Hormones and Synthetic Substitute Pharmaceuticals in the United States
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
The 2013-2018 Outlook for Synthetic Organic Medicinal Chemicals, Medicinal and Botanical Drugs and Chemicals in Bulk, Alkaloid Drugs, and Naturally Occurring Vitamins in India
The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in North America & the Caribbean
The 2013-2018 Outlook for Topical Antiseptic Medications in India
The 2023-2028 Outlook for GLP-1 Agonists for Type 2 Diabetes in China
